Garry Nolan - Dec 13, 2022 Form 4/A - Amendment Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Garry Nolan, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Dec 13, 2022
Transactions value $
-$1,325
Form type
4/A - Amendment
Date filed
3/27/2023, 08:12 PM
Date Of Original Report
Dec 15, 2022
Previous filing
Dec 6, 2022
Next filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Sale -$1.33K -100 -0.02% $13.25 555K Dec 13, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4/A is being filed to correct the date of the transaction which was inadvertently reported as occurring on 12/13/2021.